Cited by

• Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.

  Baum SE, Sierra G, Grossman D, Vizcarra E, Potter JE, White K. Baum SE, et al. Contraception. 2023 Mar;119:109912. doi: 10.1016/j.contraception.2022.11.003. Epub 2022 Dec 5. Contraception. 2023. PMID: 36473511 Free PMC article.
• Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.

  Bartlett TE, Evans I, Jones A, Barrett JE, Haran S, Reisel D, Papaikonomou K, Jones L, Herzog C, Pashayan N, Simões BM, Clarke RB, Evans DG, Ghezelayagh TS, Ponandai-Srinivasan S, Boggavarapu NR, Lalitkumar PG, Howell SJ, Risques RA, Rådestad AF, Dubeau L, Gemzell-Danielsson K, Widschwendter M. Bartlett TE, et al. Genome Med. 2022 Jun 15;14(1):64. doi: 10.1186/s13073-022-01063-5. Genome Med. 2022. PMID: 35701800 Free PMC article. Clinical Trial.
• Human Embryonic Stem Cell Research, Abortion, and Publication Bias in the New England Journal of Medicine.

  Baumgartner F. Baumgartner F. Linacre Q. 2019 Feb;86(1):103-114. doi: 10.1177/0024363919838855. Epub 2019 Apr 22. Linacre Q. 2019. PMID: 32431393 Free PMC article.
• Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling.

  Goyal V, Brooks IHM, Wallace R, Dermish AI, Kumar B, Schutt-Ainé A, Beasley A, Aiken ARA, Potter JE. Goyal V, et al. Am J Obstet Gynecol. 2020 Aug;223(2):236.e1-236.e8. doi: 10.1016/j.ajog.2020.02.028. Epub 2020 Feb 25. Am J Obstet Gynecol. 2020. PMID: 32109462 Free PMC article.
• Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol.

  Upadhyay UD, Johns NE, Cartwright AF, Franklin TE. Upadhyay UD, et al. Health Equity. 2018 Jul 1;2(1):122-130. doi: 10.1089/heq.2018.0002. eCollection 2018. Health Equity. 2018. PMID: 30283858 Free PMC article.